Lupin R&D's core strength is the ability to manage cutting edge pharmaceutical science and technology from the perspective of business.

Home to 160 scientists, the Lupin Research Park at Pune city, India, near Mumbai, is creating new families of life sciences products and services for tomorrow's marketplace. The Park houses dedicated prototypes and pilot plants for the development of a range of drugs in several therapeutic segments.

R&D at Lupin is organized around three focus areas: 

• Generics drug master files (DMFs) for APIs and abbreviated new drug applications (ANDAs) for finished products 

• New chemical entities (NCE) using the synthetic and herbal routes

• Novel drug delivery systems (NDDS)